<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04697836</url>
  </required_header>
  <id_info>
    <org_study_id>Regional anesthesia</org_study_id>
    <nct_id>NCT04697836</nct_id>
  </id_info>
  <brief_title>Cervical Plexus Block Combined With Translaryngeal Block for Tracheostomy</brief_title>
  <official_title>Can Ultrasound-Guided Bilateral Cervical Plexus Block Combined With Translaryngeal Block For Tracheostomy Be An Alternative To General Anesthesia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Namik Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Namik Kemal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Current healthcare delivery models emphasize enhanced postoperative recovery (ERAS) with&#xD;
      minimal morbidity and shorter hospital stays. Most tracheostomy cases are tumour patients.&#xD;
      The more the patients have difficulty in breathing, the more difficult it is to anaesthetize&#xD;
      them. Adequate intraoperative anaesthesia and postoperative analgesia with minimal sedation&#xD;
      play an essential role in this patient model. In tracheostomy patients, moving away from the&#xD;
      general anaesthesia option increases airway safety, and avoiding the local anaesthesia option&#xD;
      in the incision area increases patient comfort. The purpose of this study is to assess the&#xD;
      safety and efficacy of regional anaesthesia in tracheostomy patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      after being informed and about the study and potential risks, all patients giving written&#xD;
      informed consent will undergo 24 hours screening period to determine the eligilibity for&#xD;
      study entry. After a computer-generated randomization list with a 1:1 intergroup ratio,&#xD;
      ensuring equal distribution in the two groups, 30 opaque sealed envelopes numbered 1-30 were&#xD;
      prepared. The patients were randomly divided into the Group with bilateral CPB with 15 ml&#xD;
      0.5% bupivacaine or the patients with translaryngeal block with 5 ml 2% lidocaine in addition&#xD;
      to bilateral CPB.&#xD;
&#xD;
      CPB: cervical plexus block.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">November 25, 2020</completion_date>
  <primary_completion_date type="Actual">November 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>the new indication for cervical plexus block.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain score (NRS)</measure>
    <time_frame>24 hours</time_frame>
    <description>A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain related to incision</measure>
    <time_frame>24 hours</time_frame>
    <description>A numerical rating scale (NRS) requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient tolerance as assessed by tracheostomy cannula comfort score</measure>
    <time_frame>24 hours</time_frame>
    <description>= No reaction&#xD;
= Slight grimacing&#xD;
= Heavy grimacing&#xD;
= Defensive movement of hands 5= Flexion of the head with defense</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cough and gag score</measure>
    <time_frame>24 hours</time_frame>
    <description>= None&#xD;
= Slight&#xD;
= Moderate&#xD;
= Severe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>YES/NO</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time to first analgesic demand</measure>
    <time_frame>24 hours from the pacu</time_frame>
    <description>Time of first analgesic need within the first 24 hours 0: within the first 12 hours&#xD;
1: 12-24 hours</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Regional Anesthesia Morbidity</condition>
  <arm_group>
    <arm_group_label>ST (superficial cervical plexus block combined with Translareyngeal block)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Superficial cervical plexus block combined with Translareyngeal block Group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S (superficial cervical plexus block)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Superficial cervical plexus block Group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ST</intervention_name>
    <description>After a computer-generated randomization list with a 1:1 intergroup ratio, ensuring equal distribution in the two groups, 30 opaque sealed envelopes numbered 1-30 were prepared. The patients were randomly divided into the Group with bilateral CPB with 15 ml 0.5% bupivacaine or the patients with translaryngeal block with 5 ml 2% lidocaine in addition to bilateral CPB.&#xD;
Following inclusion, two research assistants, with no further involvement in the study, prepared 15mL syringes and 5 ml syringes according to the envelope's specifications. The syringes were marked with the patient's randomization number. All other investigators, staff, and patients were blinded to group allocations. Before surgery, the patients were transferred to the specified block room area monitored with 3-lead electrocardiography, pulse oximetry, and non-invasive blood pressure. All patients had two intravenous cannula lines, and then bilateral CPB block procedures were performed in awake non-sedated patients.</description>
    <arm_group_label>S (superficial cervical plexus block)</arm_group_label>
    <arm_group_label>ST (superficial cervical plexus block combined with Translareyngeal block)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Being in the age range of 18-65, with American Society of Anesthesiology (ASA)&#xD;
             classification I-III and scheduled for elective or emergency tracheostomy.&#xD;
&#xD;
          -  A sufficient level of education to understand the study procedures and agree to&#xD;
             participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to cooperate&#xD;
&#xD;
          -  dementia,&#xD;
&#xD;
          -  allergy to local anesthetics and opioids&#xD;
&#xD;
          -  regular daily opioid requirements&#xD;
&#xD;
          -  abuse of alcohol or medication&#xD;
&#xD;
          -  local infection at the site of injection or systemic infection,&#xD;
&#xD;
          -  pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AYHAN ŞAHİN</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Director</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Namık Kemal University</name>
      <address>
        <city>Tekirdağ</city>
        <state>Süleymanpaşa</state>
        <zip>59100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Mehta AB, Syeda SN, Bajpayee L, Cooke CR, Walkey AJ, Wiener RS. Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012. Am J Respir Crit Care Med. 2015 Aug 15;192(4):446-54. doi: 10.1164/rccm.201502-0239OC.</citation>
    <PMID>25955332</PMID>
  </reference>
  <reference>
    <citation>Bradley PJ. Treatment of the patient with upper airway obstruction caused by cancer of the larynx. Otolaryngol Head Neck Surg. 1999 May;120(5):737-41. Review.</citation>
    <PMID>10229602</PMID>
  </reference>
  <reference>
    <citation>Freeman BD. Indications for and management of tracheostomy. In: Vincent JL, Abraham E, Moore FA, et al, editors. Textbook of critical care. 6th edition. Phila- delphia: Elsevier/W. B. Saunders; 2011. p. 369-72</citation>
  </reference>
  <reference>
    <citation>Moorthy SS, Gupta S, Laurent B, Weisberger EC. Management of airway in patients with laryngeal tumors. J Clin Anesth. 2005 Dec;17(8):604-9. doi: 10.1016/j.jclinane.2004.12.019. Erratum in: J Clin Anesth. 2006 Mar;18(2):163-4. PMID: 16427530</citation>
  </reference>
  <reference>
    <citation>Kim JS, Ko JS, Bang S, Kim H, Lee SY. Cervical plexus block. Korean J Anesthesiol. 2018 Aug;71(4):274-288. doi: 10.4097/kja.d.18.00143. Epub 2018 Jul 4.</citation>
    <PMID>29969890</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 25, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 4, 2021</last_update_submitted>
  <last_update_submitted_qc>January 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Namik Kemal University</investigator_affiliation>
    <investigator_full_name>Ayhan ŞAHİN</investigator_full_name>
    <investigator_title>Asistant Prof</investigator_title>
  </responsible_party>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Tracheostomy</keyword>
  <keyword>Ultrasound</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Demographic and clinical features of the study groups.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>study is finished</ipd_time_frame>
    <ipd_access_criteria>public</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 27, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/36/NCT04697836/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 27, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/36/NCT04697836/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

